间皮素作为癌症免疫治疗的生物标志物和治疗靶点
Mesothelin as Biomarker and Therapeutic Target for Immunotherapy in Cancer.
癌症仍是一个关键的全球健康问题,原因在于发现晚、耐药和高死亡率。
CELL INTELLIGENCE · 肿瘤细胞治疗研究
肿瘤细胞治疗研究
英文原题:Intratumoral Foxp3(+)RORγt(+) T cell infiltration determines poor prognosis and immunoevasive contexture in gastric cancer patients.
Intratumoral Foxp3(+)RORγt(+) T cell infiltration determines poor prognosis and immunoevasive contexture in gastric cancer patients.
分数与星级只用于站内排序 —— 不代表疗效、安全性或个人适用性。
我们发现 Foxp3 + RORγt + T 细胞可能削弱 CD8 + T 细胞的有效功能,并导致不良的生存结局和较差的化疗反应性。此外,这种新型联合评估系统可能有助于胃癌的预后预测,以指导合适的治疗。新颖性与影响声明:Foxp3 + RORγt + T 细胞在胃癌中的临床意义尚未被研究。在此,我们在 452 例患者中研究了 Foxp3+RORγt+ T 细胞的预后价值。我们证明,瘤内 Foxp3 + RORγt + T 细胞浸润是总生存期的预后生物标志物,并且可识别可能从胃切除术后 5-氟尿嘧啶治疗中获益的患者。
Foxp3 + RORγt + T细胞兼具调节性T细胞和辅助性T细胞17的特征,在自身免疫性疾病中显示出显著的免疫调节功能。然而,Foxp3 + RORγt + T细胞在胃癌中的作用及临床意义尚不清楚。
我们纳入了来自中山医院的452例胃癌组织芯片样本和60例新鲜肿瘤组织样本。通过免疫组织化学和流式细胞术检测了Foxp3 + RORγt + T细胞的浸润情况及免疫微环境。通过Kaplan-Meier曲线、log-rank检验和Cox比例风险模型对患者亚组进行了生存分析。
Foxp3 + RORγt + T 细胞高浸润预示胃癌患者总生存期较差(P = 0.0222 和 0.0110)和治疗反应不佳(交互作用 P = 0.003)。Foxp3 + RORγt + T 细胞与 CD8 + T 细胞有效功能受损相关,表现为干扰素-γ、颗粒酶 B 和 CD107a 表达降低。联合评估 Foxp3 + RORγt + T 细胞和 CD8 + T 细胞可更精确地预测生存结局和化疗反应性。
Foxp3 + RORγt + T cells possess both characteristics of regulatory T cells and T helper 17 cells and show significant immunoregulatory functions in autoimmune diseases. However, the role and clinical significance of Foxp3 + RORγt + T cells in gastric cancer remains unclear.
We enrolled 452 gastric cancer tissue microarray samples and 60 fresh tumor tissue samples from Zhongshan Hospital. The infiltration of Foxp3 + RORγt + T cells and immune contexture were examined by immunohistochemistry and flow cytometry. Survival analyses of patient subgroups were conducted by Kaplan-Meier curves, log-rank test and Cox proportional model.
High infiltration of Foxp3 + RORγt + T cells predicted poor overall survival (P = 0.0222 and 0.0110) and inferior therapeutic response (P = 0.003 for interaction) in gastric cancer. Foxp3 + RORγt + T cells were associated with impaired effective function of CD8 + T cells featured by decreased interferon-γ, granzyme B and CD107a expression. Co-evaluation of Foxp3 + RORγt + T cells and CD8 + T cells could predict survival outcomes and chemotherapeutic responsiveness more precisely.
We found that Foxp3 + RORγt + T cells could potentially attenuate effective functions of CD8 + T cells and led to adverse survival outcomes and inferior chemotherapeutic responsiveness. Moreover, the novel co-evaluation system might be useful for prognosis prediction for appropriate treatment in gastric cancer. NOVELTY AND IMPACT STATEMENTS: Clinical significance of Foxp3 + RORγts + T cells has not been studied in gastric cancer. Herein, we investigated the prognostic value of Foxp3+RORγt+ T cells in 452 patients. We demonstrated that intratumoral Foxp3 + RORγt + T cell infiltration was a prognostic biomarker for overall survival and the identification of patients might benefit from post-gastrectomy 5-fluorouracil. These findings allow a more precise stratification upon the co-evaluation with CD8 + T cells to better clinical management for patients who would benefit from 5-fluorouracil.
在 PubMed 查看 → 出版商原文(DOI) 全文 PDF(PMC)· 可下载 治疗专题与资料阅读指南 资料来源与翻译说明 报告译文或资料问题 →
MEMBER ACCOUNT
登录成功会直接打开下一页。